Dr. Leonhardt explains that: firstly the number of injections necessary: there’s the possibility of three-time injection, including Synvisc, this is the classic. There are a number of drugs have to be injected five times but the risk of infection increases with each injection into the joint. “Now there are substances which have to be injected only once and then for a year and longer, such as Synvisc-one .” Tailor-made: motivation program but when it comes to help osteoarthritis patients, not only in the short term, but permanently to more mobility and quality of life requires the conversion of general life habits such as exercise and diet for osteoarthritis. Prerequisites for this are high motivation and active participation. For more information see Adroll. We have developed the Zurich resource model (ZRM) at the University of Zurich. This is motivational psychology of the 3rd millennium,”reported Dr.
Storch. Based on this model, the owner of the Institute has developed a special motivation program for osteoarthritis patients for self-management and motivation of Zurich (ISMZ) how to the inner pig dog actually successfully and sustainably overcome with concrete instructions, to lay the groundwork for a successful management of osteoarthritis. Stork demonstrates why it so difficult to translate good intentions actually into the fact: If one was elected at the dodgeball at school always as a last, then this is stored. Later, negatively evaluated relevant keywords within milliseconds. “And even if I know here very closely from the mind that sports good for me, I will not implement this action to I need to work on the setting.” But how can be achieved after successful setting change it sustainable changeover in everyday life? “Dr.
Storch does: so I won’t automatically fall back into old exercise or eating habits, I’m an if-then plan, for example: when the alarm goes off, I’m getting in my sneakers.” Studies show that after hip surgery, is that performing mobilization exercises by two-thirds can be increased if the exercises with if then plans are addressed. About Genzyme’s Genzyme headquartered in Cambridge, Massachusetts (United States) among the world’s leading biotechnology companies. Since its founding in 1981, Genzyme from a small start-up has developed to one of the most successful companies in the biotechnology sector with more than 12,000 employees in over 40 countries. In the last two decades, Genzyme has brought a variety of breakthrough therapies for some not previously treatable diseases on the market, to help patients in approximately 100 countries. The biotechnology company the area of focus for its research activities rare disorders (orphan diseases) and there is the focus on the Lysosomal Storage diseases. In addition, Nephrology and cardiovascular diseases, transplantation medicine and the fields of autoimmune diseases, oncology and malignant thyroid disease and orthopedic applications belong to the research and the field of activity of the company. On the German site in Neu-Isenburg, over 180 employees perceive mainly sales activities and pursue an ethically responsible and service-oriented cooperation with medical professionals and patients.